Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role
Hao Zhang(Northwestern Polytechnical University), Quan Cheng(Central South University), Peng Luo(Zhujiang Hospital), Nan Zhang(Huazhong University of Science and Technology), Zeyu Wang(Anhui University), Jian Zhang(Zhujiang Hospital), Songshan Feng(Central South University), Ruixuan Wang(Chinese Academy of Fishery Sciences), Yun Peng(Chinese University of Hong Kong), Zaoqu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jason Hu(Illumina (United States)), Longbo Zhang(Shandong University of Technology), Wantao Wu(Central South University)
Cited by 48
Related Papers
NF-κB in biology and targeted therapy: new insights and translational implications
|Signal Transduction and Targeted Therapy|2024|1.6k
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
|Journal of Hematology & Oncology|2020|400